NM_004360.5(CDH1):c.2370C>T (p.Thr790=) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Dec 22, 2019
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002454211.2
Allele description [Variation Report for NM_004360.5(CDH1):c.2370C>T (p.Thr790=)]
NM_004360.5(CDH1):c.2370C>T (p.Thr790=)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
Clinical and Economic Review Report: Infliximab SC (Remsima)
Clinical and Economic Review Report: Infliximab SC (Remsima)
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024